Local delivery of chemotherapy: a supplement to existing cancer treatments. A case for surgical pastes and coated stents.

作者: William L Hunter , Helen M Burt , Lindsay Machan

DOI: 10.1016/S0169-409X(97)00035-5

关键词:

摘要: Abstract Local application or direct tumor injection of chemotherapeutic drugs has been proposed as a method by which local drug concentrations can be maximized in the immediate environment while systemic exposure and non-target organ toxicity is minimized. Multiple opportunities are available to combine delivery with widely practised, existing medical surgical therapies. Surgical interventions, including both open laparoscopic procedures, allow physician directly visualize manipulate pathological tissues. Intraoperative placement implantable therapeutic compounds (barriers prevent adhesions, sustained-release antibiotics, tissue `glues' hemostatic agents) at near disease site increasingly common practice. Less invasive therapies assisted diagnostic imaging (fluoroscopy, ultrasound, CT MRI scanning) have made accurate needle catheter for drainage (abscesses, cysts, obstructions), (contrast media, pharmacological agents, embolic purposes (endoluminal stents, venous filters) practised interventional procedures. This article describes polymer-based paste we developed time surgery reduce recurrence resection sites polymer-coated stent use palliative management malignant obstruction improve effective lifespan device (e.g., esophageal, biliary, prostate, pulmonary disease). Despite growth therapy other states, regional cytotoxic not deployed malignancy due clinical bias that will limited utility what considered disease. In above manner, could incorporated into protocols designed enhance, replace, efficacy treatment options.

参考文章(42)
J. S. Fisherman, J. A. O'Shaughnessy, K. H. Cowan, Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer. Seminars in Oncology. ,vol. 21, pp. 19- 23 ,(1994)
B. D. Tarr, T. G. Sambandan, S. H. Yalkowsky, A new parenteral emulsion for the administration of taxol. Pharmaceutical Research. ,vol. 4, pp. 162- 165 ,(1987) , 10.1023/A:1016483406511
Robert S. Langer, Mark Chasin, Biodegradable polymers as drug delivery systems M. Dekker. ,(1990)
Mark E. Stearns, Min Wang, Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer Research. ,vol. 52, pp. 3776- 3781 ,(1992)
Amarnath Sharma, Robert M. Straubinger, Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharmaceutical Research. ,vol. 11, pp. 889- 896 ,(1994) , 10.1023/A:1018994111594
Charles I. Winternitz, John K. Jackson, Ann Marie Oktaba, Helen M. Burt, Development of a polymeric surgical paste formulation for taxol. Pharmaceutical Research. ,vol. 13, pp. 368- 375 ,(1996) , 10.1023/A:1016032207246
David S. Ettinger, Philip J. Burke, Robert W. Tucker, Ross C. Donehower, Eric K. Rowinsky, Judith E. Karp, Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Research. ,vol. 49, pp. 4640- 4647 ,(1989)
Henry Brem, Abraham Domb, Mitchell A. Cahan, John Hilton, Peter C. Burger, Betty Tyler, Kevin A. Walter, O. Michael Colvin, Aya Gur, Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Research. ,vol. 54, pp. 2207- 2212 ,(1994)
Kent E. Wallner, Joseph H. Galicich, George Krol, Ehud Arbit, Mark G. Malkin, Patterns of Failure Following Treatment for Glioblastoma Multiforme and Anaplastic Astrocytoma International Journal of Radiation Oncology Biology Physics. ,vol. 16, pp. 1405- 1409 ,(1989) , 10.1016/0360-3016(89)90941-3
R Alvarado, J C Palmaz, O J Garcia, F O Tio, C R Rees, Evaluation of polymer-coated balloon-expandable stents in bile ducts. Radiology. ,vol. 170, pp. 975- 978 ,(1989) , 10.1148/RADIOLOGY.170.3.2916065